{"id":"oral-propranolol","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Fatigue"},{"rate":"5-10","effect":"Dizziness"},{"rate":"5-10","effect":"Bradycardia"},{"rate":"5-10","effect":"Hypotension"},{"rate":"5","effect":"Nausea"},{"rate":"1-5","effect":"Bronchospasm (in susceptible patients)"},{"rate":"2-5","effect":"Sexual dysfunction"},{"rate":"2-5","effect":"Insomnia"}]},"_chembl":{"chemblId":"CHEMBL1671","moleculeType":"Small molecule","molecularWeight":"295.81"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Propranolol competitively inhibits beta-1 and beta-2 adrenergic receptors throughout the body. This reduces heart rate, cardiac contractility, and blood pressure, and also decreases renin release from the kidneys. These effects make it useful for managing hypertension, angina, arrhythmias, and other cardiovascular conditions.","oneSentence":"Propranolol is a non-selective beta-adrenergic receptor antagonist that blocks the effects of epinephrine and norepinephrine on the heart and blood vessels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:46.797Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina pectoris"},{"name":"Cardiac arrhythmias (including atrial fibrillation and supraventricular tachycardia)"},{"name":"Myocardial infarction (secondary prevention)"},{"name":"Essential tremor"},{"name":"Migraine prophylaxis"},{"name":"Hyperthyroidism (symptomatic management)"}]},"trialDetails":[{"nctId":"NCT06798363","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2025-05-02","conditions":"Infantile Hemangioma","enrollment":40},{"nctId":"NCT06972056","phase":"PHASE4","title":"Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-07-09","conditions":"Migraine","enrollment":1335},{"nctId":"NCT06120140","phase":"PHASE2","title":"Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-02-16","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":300},{"nctId":"NCT07452978","phase":"PHASE2","title":"Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Tours","startDate":"2026-09-01","conditions":"PTSD - Post Traumatic Stress Disorder","enrollment":34},{"nctId":"NCT05797662","phase":"PHASE2","title":"A Study of Propranolol to Treat Kaposi Sarcoma","status":"NOT_YET_RECRUITING","sponsor":"AIDS Malignancy Consortium","startDate":"2026-09","conditions":"Kaposi Sarcoma","enrollment":25},{"nctId":"NCT07352228","phase":"PHASE4","title":"Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic Varices","status":"ENROLLING_BY_INVITATION","sponsor":"Xijing Hospital","startDate":"2026-01-01","conditions":"Rebleeding of Portal Hypertension in Liver Cirrhosis, Propranolol, Carvedilol","enrollment":350},{"nctId":"NCT07353294","phase":"PHASE1","title":"Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2026-01-01","conditions":"Bladder Urothelial Carcinoma, Lymph Node Metastasis","enrollment":12},{"nctId":"NCT01988883","phase":"EARLY_PHASE1","title":"Modafinil and Cognitive Function in POTS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2014-10","conditions":"Postural Tachycardia Syndrome","enrollment":20},{"nctId":"NCT07091279","phase":"PHASE2","title":"Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism","status":"RECRUITING","sponsor":"Jeremy Veenstra-vanderweele","startDate":"2026-01-22","conditions":"Autism Spectrum Disorder, Challenging Behaviour, Aggression","enrollment":60},{"nctId":"NCT07311915","phase":"NA","title":"Propranolol Combined With Novel Endocrine Therapy and Androgen Deprivation Therapy (ADT) for Neoadjuvant Treatment in High-Risk Prostate Cancer Patients: A Multicenter, Single-Arm Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Zhongda Hospital","startDate":"2026-01-15","conditions":"Prostate Cancer","enrollment":30},{"nctId":"NCT05387512","phase":"","title":"A Real World Study of β2-Adrenergic Blocker Plus PD-1 Inhibitor in Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-01-12","conditions":"Lung Cancer","enrollment":59},{"nctId":"NCT07271485","phase":"EARLY_PHASE1","title":"Propranolol for Misophonia","status":"RECRUITING","sponsor":"Bloom Mental Health, LLC","startDate":"2025-12-19","conditions":"Misophonia, Propanolol, Misophonia Treatment","enrollment":20},{"nctId":"NCT04713657","phase":"PHASE1","title":"Beta-blocker Administration for Cardiomyocyte Division","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2022-12-16","conditions":"Tetralogy of Fallot, Double Outlet Right Ventricle","enrollment":40},{"nctId":"NCT06263452","phase":"PHASE4","title":"Beta-Blocker Influences on Inflammatory and Neural Responses to Stress","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-05-01","conditions":"Cardiovascular Disease","enrollment":120},{"nctId":"NCT06833320","phase":"PHASE1, PHASE2","title":"Propranolol Treatment for Postoperative Chylothorax","status":"RECRUITING","sponsor":"June Wu","startDate":"2025-09-09","conditions":"Postoperative Chylothorax, Congenital Heart Disease, Open Heart Surgery","enrollment":50},{"nctId":"NCT07180043","phase":"NA","title":"Propranolol for Pediatric Migraine: A Prospective Clinical Study","status":"COMPLETED","sponsor":"Kayseri University","startDate":"2021-01-01","conditions":"Pediatric Migraine, Headache Disorders","enrollment":178},{"nctId":"NCT05968690","phase":"PHASE1","title":"Naltrexone and Propranolol Combined With Immunotherapy","status":"RECRUITING","sponsor":"Sarah Weiss","startDate":"2023-09-11","conditions":"Advanced Melanoma","enrollment":12},{"nctId":"NCT06417177","phase":"EARLY_PHASE1","title":"Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia","status":"RECRUITING","sponsor":"University of Missouri-Columbia","startDate":"2024-06-03","conditions":"Aging, Menopause, Hypoxia","enrollment":75},{"nctId":"NCT04921982","phase":"PHASE2","title":"Efficacy of Traumatic Memory Modification Using Memory Reconsolidation and Propranolol Among Adolescents With PTSD","status":"WITHDRAWN","sponsor":"Rennes University Hospital","startDate":"2024-10","conditions":"Post Traumatic Stress Disorder","enrollment":""},{"nctId":"NCT03588754","phase":"PHASE2","title":"Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2018-09-15","conditions":"Alcohol Drinking","enrollment":20},{"nctId":"NCT07113015","phase":"NA","title":"A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease","status":"COMPLETED","sponsor":"Multan Medical And Dental College","startDate":"2024-07-05","conditions":"Parkinson Disease (PD), Tremor","enrollment":220},{"nctId":"NCT07103031","phase":"","title":"Comorbidity-Based Propranolol Use in Pediatric Migraine","status":"COMPLETED","sponsor":"Kayseri University","startDate":"2021-01-01","conditions":"Pediatric Migraine, Migraine Disorders, Brain, Vitamin D Deficiency","enrollment":488},{"nctId":"NCT07104526","phase":"NA","title":"Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH)","status":"COMPLETED","sponsor":"Wuhan Integrated Traditional Chinese and Western Medicine Hospital","startDate":"2024-01-01","conditions":"Infantile Hemangioma (IH)","enrollment":260},{"nctId":"NCT06982183","phase":"PHASE4","title":"The Effects of Propranolol, Hydrocortisone, and Morphine on Military-Relevant Performance Outcomes","status":"RECRUITING","sponsor":"Walter Reed Army Institute of Research (WRAIR)","startDate":"2025-05-27","conditions":"Fear of Spiders, Acute Stress Reaction","enrollment":110},{"nctId":"NCT06839144","phase":"PHASE2","title":"Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression","status":"RECRUITING","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2025-03-12","conditions":"Ovarian Cancer, Ovarian Cancer Metastatic Recurrent","enrollment":60},{"nctId":"NCT03633747","phase":"PHASE1, PHASE2","title":"Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma","status":"TERMINATED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2018-07-01","conditions":"Hemangioma Liver","enrollment":8},{"nctId":"NCT05173012","phase":"PHASE2","title":"Study to Evaluate SAGE-324 in Participants With Essential Tremor","status":"COMPLETED","sponsor":"Sage Therapeutics","startDate":"2022-01-05","conditions":"Essential Tremor","enrollment":146},{"nctId":"NCT06863558","phase":"PHASE3","title":"Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Intracerebral Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-05-08","conditions":"Intracerebral Hemorrhage","enrollment":58},{"nctId":"NCT06960850","phase":"NA","title":"Effects of Oral Propranolol on Induction-Delivery Interval During Induction of Labour With Oxytocin","status":"NOT_YET_RECRUITING","sponsor":"Federal Teaching Hospital Abakaliki","startDate":"2025-06-01","conditions":"Propranolol, Labour Induction","enrollment":308},{"nctId":"NCT03882255","phase":"PHASE1","title":"A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady State","status":"COMPLETED","sponsor":"Janssen Pharmaceutica N.V., Belgium","startDate":"2019-03-20","conditions":"Healthy","enrollment":52},{"nctId":"NCT06863571","phase":"PHASE3","title":"Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic Stroke","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-04-12","conditions":"Ischemic Stroke","enrollment":68},{"nctId":"NCT06836856","phase":"PHASE1, PHASE2","title":"Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2025-01-20","conditions":"TBI Traumatic Brain Injury","enrollment":100},{"nctId":"NCT06066710","phase":"EARLY_PHASE1","title":"Propranolol in Primary Progressive Aphasia","status":"RECRUITING","sponsor":"University of Missouri-Columbia","startDate":"2025-01-13","conditions":"Aphasia, Primary Progressive","enrollment":30},{"nctId":"NCT06775080","phase":"PHASE2","title":"The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2024-12-01","conditions":"Gastrointestinal Tumors","enrollment":40},{"nctId":"NCT03083431","phase":"PHASE2","title":"Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity","status":"RECRUITING","sponsor":"University of Zurich","startDate":"2022-09-22","conditions":"Retinopathy of Prematurity","enrollment":276},{"nctId":"NCT06719804","phase":"EARLY_PHASE1","title":"Propranolol Adjuvant Treatment of Focal Refractory Epilepsy (PATFRE)","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-12-05","conditions":"Epilepsy, Drug Resistant","enrollment":15},{"nctId":"NCT01950520","phase":"PHASE2","title":"Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2014-02-07","conditions":"Healthy Volunteers","enrollment":47},{"nctId":"NCT06509503","phase":"PHASE4","title":"Impact of Combined Oral Contraceptive Pills on Migraine","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-07-15","conditions":"Migraine","enrollment":400},{"nctId":"NCT03049306","phase":"PHASE2","title":"Propranolol for Sleep Apnea Therapy","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-02-15","conditions":"Obstructive Sleep Apnea","enrollment":24},{"nctId":"NCT05679193","phase":"PHASE2","title":"Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2023-01-02","conditions":"Prostate Cancer","enrollment":40},{"nctId":"NCT03474614","phase":"PHASE2","title":"Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation","status":"TERMINATED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2018-01-24","conditions":"Cerebral Cavernous Malformations","enrollment":4},{"nctId":"NCT06145074","phase":"PHASE2","title":"Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC.","status":"RECRUITING","sponsor":"Zealand University Hospital","startDate":"2024-03-20","conditions":"Pancreatic Cancer, Surgery","enrollment":30},{"nctId":"NCT02428205","phase":"NA","title":"Combined Effects of Early Behavioral Intervention and Propranolol on ASD","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2015-04","conditions":"Autism","enrollment":10},{"nctId":"NCT06262061","phase":"EARLY_PHASE1","title":"Propranolol for the Treatment of Traumatic Brain Injury","status":"UNKNOWN","sponsor":"London Health Sciences Centre","startDate":"2024-03","conditions":"TBI (Traumatic Brain Injury)","enrollment":50},{"nctId":"NCT05189977","phase":"PHASE1","title":"A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline","status":"TERMINATED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2022-09-07","conditions":"Post-traumatic Stress Disorder (PTSD)","enrollment":34},{"nctId":"NCT05859009","phase":"NA","title":"Primary Prevention of Gastric Varices Bleed","status":"WITHDRAWN","sponsor":"Unity Health Toronto","startDate":"2023-07-01","conditions":"Gastric Varices Bleeding, Endoscopic Ultrasound","enrollment":""},{"nctId":"NCT05424016","phase":"NA","title":"Propranolol and Von Hippel-Lindau Disease","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-01-16","conditions":"Hemangioblastoma of CNS, Von Hippel-Lindau Disease","enrollment":85},{"nctId":"NCT06014606","phase":"NA","title":"Learning and Decision-making","status":"COMPLETED","sponsor":"Maastricht University","startDate":"2021-03-01","conditions":"Motivation","enrollment":150},{"nctId":"NCT04985344","phase":"PHASE3","title":"Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2023-02-01","conditions":"PTSD","enrollment":92},{"nctId":"NCT03893617","phase":"PHASE1","title":"Brief Stresses Experimental Study","status":"TERMINATED","sponsor":"Dana Bovbjerg","startDate":"2017-10-05","conditions":"DNA Damage, Psychological Stress","enrollment":239},{"nctId":"NCT02790736","phase":"PHASE4","title":"Brief Intervention to Reduce Fear of Public Speaking","status":"TERMINATED","sponsor":"New York State Psychiatric Institute","startDate":"2016-06","conditions":"Social Anxiety Disorder","enrollment":6},{"nctId":"NCT05692869","phase":"NA","title":"A Study of Continuous Blood Pressure Monitoring in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2023-01-31","conditions":"Healthy","enrollment":24},{"nctId":"NCT02153944","phase":"PHASE4","title":"Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2014-06-16","conditions":"Anxiety Disorder","enrollment":142},{"nctId":"NCT02620579","phase":"PHASE2","title":"Biopsychosocial Influence on Shoulder Pain","status":"COMPLETED","sponsor":"Duke University","startDate":"2016-01","conditions":"Shoulder Pain","enrollment":264},{"nctId":"NCT01851252","phase":"PHASE1","title":"MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy","status":"COMPLETED","sponsor":"Meridian Bioscience, Inc.","startDate":"2013-10","conditions":"Chronic Liver Disease, Cirrhosis, Esophageal Varices","enrollment":19},{"nctId":"NCT02342275","phase":"PHASE3","title":"Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile Hemangioma","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2013-10","conditions":"Hemangioma","enrollment":377},{"nctId":"NCT04113187","phase":"PHASE3","title":"Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2020-06-23","conditions":"Hereditary Hemorrhagic Telangiectasia, Osler Weber Rendu Disease","enrollment":15},{"nctId":"NCT05375240","phase":"PHASE2","title":"Propranolol on Post Stroke Immune Status and Infection","status":"UNKNOWN","sponsor":"Tianjin Medical University General Hospital","startDate":"2022-06","conditions":"Stroke, Cerebrovascular Disorders, Ischemic Stroke","enrollment":45},{"nctId":"NCT03589014","phase":"PHASE2","title":"Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2018-04-11","conditions":"Cerebral Cavernous Malformation","enrollment":71},{"nctId":"NCT05251610","phase":"NA","title":"Does Oral Propranolol Accelerate Labor Induction/Augmentation With Oxytocin in Nulliparous Women in Abakaliki?","status":"COMPLETED","sponsor":"Darlington-Peter Chibuzor Ugoji","startDate":"2020-11-02","conditions":"Duration of Labor","enrollment":110},{"nctId":"NCT01902966","phase":"NA","title":"Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-09-11","conditions":"Cervical Cancer","enrollment":6},{"nctId":"NCT00687700","phase":"PHASE1","title":"A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers","status":"COMPLETED","sponsor":"Theravance Biopharma","startDate":"2008-03-10","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":23},{"nctId":"NCT04320589","phase":"PHASE2","title":"the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma","status":"COMPLETED","sponsor":"National Cancer Institute, Egypt","startDate":"2019-06-30","conditions":"Pheochromocytoma","enrollment":30},{"nctId":"NCT01010308","phase":"PHASE2","title":"Nadolol for Proliferating Infantile Hemangiomas","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2009-11","conditions":"Infantile Hemangioma","enrollment":20},{"nctId":"NCT03783065","phase":"NA","title":"HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803)","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2019-01-02","conditions":"Portal Hypertension, Variceal Rebleeding","enrollment":40},{"nctId":"NCT04982211","phase":"PHASE2","title":"Comparing Standard vs. Modified Reconsolidation Blockade for the Treatment of Psychological Trauma","status":"UNKNOWN","sponsor":"Douglas Mental Health University Institute","startDate":"2021-08-01","conditions":"Trauma and Stressor Related Disorders, Post Traumatic Stress Disorder, Acute Stress Disorder","enrollment":150},{"nctId":"NCT01555554","phase":"NA","title":"Perioperative Propranolol in Patients With Post Traumatic Stress Disorder (PTSD)","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2012-05","conditions":"Post-traumatic Stress Disorder","enrollment":59},{"nctId":"NCT03152175","phase":"PHASE2","title":"Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators","status":"UNKNOWN","sponsor":"Douglas Mental Health University Institute","startDate":"2017-03-30","conditions":"Trauma and Stressor Related Disorders, Post-traumatic Stress Disorders, Adjustment Disorders","enrollment":64},{"nctId":"NCT00748059","phase":"PHASE1","title":"The Pathophysiology of Orthostatic Hypotension","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"1996-12","conditions":"Autonomic Nervous System Diseases, Orthostatic Hypotension, Dopamine Beta-Hydroxylase Deficiency","enrollment":10},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT04682184","phase":"NA","title":"A Study of Continuous Heart Rate Monitoring in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2021-01-27","conditions":"Healthy","enrollment":21},{"nctId":"NCT03388957","phase":"NA","title":"Oral Propranolol for Reducing Pediatric Dental Patients Anxiety","status":"COMPLETED","sponsor":"Damascus University","startDate":"2018-07-30","conditions":"Extrusion of Tooth","enrollment":60},{"nctId":"NCT04494763","phase":"NA","title":"Primary Prophylaxis for Variceal Bleed in Biliary Atresia","status":"UNKNOWN","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-08-15","conditions":"Portal Hypertension, Biliary Atresia","enrollment":92},{"nctId":"NCT04421209","phase":"PHASE2","title":"Analgesic Effects of Perioperative Propranolol Administration for Spine Surgery","status":"WITHDRAWN","sponsor":"Duke University","startDate":"2020-12","conditions":"Lumbar Disc Disease, Spinal Fusion, Degenerative Disc Disease","enrollment":""},{"nctId":"NCT01791114","phase":"NA","title":"The Effect of Brown Adipose Tissue Activation on Insulin Sensitivity in Humans","status":"COMPLETED","sponsor":"Rutgers University","startDate":"2012-01","conditions":"Insulin Sensitivity, Obesity","enrollment":39},{"nctId":"NCT04651049","phase":"","title":"Systemic Propranolol for the Treatment of Paediatric Patients With Infantile Hemangiomas","status":"COMPLETED","sponsor":"Qilu Hospital of Shandong University","startDate":"2010-07-15","conditions":"Infantile Haemangiomas","enrollment":128},{"nctId":"NCT02505971","phase":"PHASE3","title":"Nadolol Versus Propranolol in Children With Infantile Hemangiomas","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2015-09","conditions":"Infantile Hemangioma","enrollment":74},{"nctId":"NCT04580342","phase":"PHASE2","title":"Ivabradine Versus Propranolol for Induced Hypotension in Endoscopic Sinus Surgery","status":"UNKNOWN","sponsor":"Ahmed talaat ahmed aly","startDate":"2020-10-15","conditions":"Hypotension","enrollment":60},{"nctId":"NCT02871349","phase":"EARLY_PHASE1","title":"Trial of Propranolol in Children and Youth With Autism Spectrum Disorder and Predictors of Response","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2016-08","conditions":"Autism Spectrum Disorder","enrollment":69},{"nctId":"NCT03161964","phase":"PHASE2","title":"Propranolol in Treating Hypoglycemia Unawareness","status":"TERMINATED","sponsor":"Anu Sharma","startDate":"2017-10-19","conditions":"Type 1 Diabetes Mellitus","enrollment":2},{"nctId":"NCT04493489","phase":"PHASE2","title":"Propranolol Adjuvant Treatment of Bladder Cancer","status":"UNKNOWN","sponsor":"Central South University","startDate":"2020-09-06","conditions":"Bladder Cancer","enrollment":242},{"nctId":"NCT04406870","phase":"PHASE4","title":"Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH)","status":"UNKNOWN","sponsor":"Shanghai Children's Medical Center","startDate":"2020-07","conditions":"Hemangioendothelioma of Liver","enrollment":36},{"nctId":"NCT02268357","phase":"PHASE2, PHASE3","title":"The Effects of Propranolol on Fear of Tooth or Molar Extraction","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2014-11","conditions":"Dental Anxiety","enrollment":36},{"nctId":"NCT04288700","phase":"PHASE4","title":"Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-10-01","conditions":"Infantile Hemangioma","enrollment":100},{"nctId":"NCT01822587","phase":"PHASE2","title":"Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2013-09","conditions":"Cocaine Addiction","enrollment":181},{"nctId":"NCT04208594","phase":"NA","title":"Efficacy of Ivabradine Versus Propranolol Premedication During Hypotensive Anesthesia in Endoscopic Sinus Surgery","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2019-12-11","conditions":"Ivabradine, Propranolol, Hypotensive Anesthesia","enrollment":50},{"nctId":"NCT00688805","phase":"PHASE1","title":"Effects of Propranolol on Responses to Drug-Related Imagery Scripts","status":"TERMINATED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2007-12-12","conditions":"Cocaine Dependence","enrollment":40},{"nctId":"NCT03270644","phase":"PHASE1","title":"A Study of Lasmiditan and Propranolol in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2017-08-31","conditions":"Healthy","enrollment":44},{"nctId":"NCT02452255","phase":"PHASE2, PHASE3","title":"Fenofibrate and Propranolol in Burn Patients","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2015-11","conditions":"Burn","enrollment":18},{"nctId":"NCT01902810","phase":"PHASE2, PHASE3","title":"Protective Effects of Propranolol in Adults","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2013-07","conditions":"Burn","enrollment":47},{"nctId":"NCT00675714","phase":"PHASE2, PHASE3","title":"Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2004-01","conditions":"Burns","enrollment":1126},{"nctId":"NCT03838029","phase":"PHASE2","title":"Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2019-11-20","conditions":"Pancreatic Neoplasms","enrollment":210},{"nctId":"NCT01618890","phase":"PHASE3","title":"Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2012-09","conditions":"Acute Bleeding Esophageal Varices, Liver Cirrhosis","enrollment":78},{"nctId":"NCT01957449","phase":"PHASE2, PHASE3","title":"Propranolol in Severely Burned Children","status":"TERMINATED","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2013-12","conditions":"Burn","enrollment":63},{"nctId":"NCT01504126","phase":"EARLY_PHASE1","title":"Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2012-03-09","conditions":"Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma","enrollment":32},{"nctId":"NCT02437383","phase":"PHASE2","title":"Study of Orofacial Pain and PropRANOlol","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2015-08-20","conditions":"Temporomandibular Disorders","enrollment":200},{"nctId":"NCT03919461","phase":"PHASE2","title":"Colorectal Metastasis Prevention International Trial 2","status":"RECRUITING","sponsor":"Assaf-Harofeh Medical Center","startDate":"2019-02-28","conditions":"Colorectal Neoplasms","enrollment":200},{"nctId":"NCT01070225","phase":"PHASE4","title":"Reversal of Acute β-Blocker Induced Bronchoconstriction","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2010-03","conditions":"Asthma","enrollment":14},{"nctId":"NCT03254186","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2017-09-18","conditions":"Tardive Dyskinesia","enrollment":""},{"nctId":"NCT03524066","phase":"NA","title":"Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF)","status":"COMPLETED","sponsor":"Fraunhofer-Institute of Toxicology and Experimental Medicine","startDate":"2018-04-10","conditions":"Healthy","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":903,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Inderal (long-acting)","Inderal","Innopran","beta blocker"],"phase":"marketed","status":"active","brandName":"oral Propranolol","genericName":"oral Propranolol","companyName":"Ahmed talaat ahmed aly","companyId":"ahmed-talaat-ahmed-aly","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Propranolol is a non-selective beta-adrenergic receptor antagonist that blocks the effects of epinephrine and norepinephrine on the heart and blood vessels. Used for Hypertension, Angina pectoris, Cardiac arrhythmias (including atrial fibrillation and supraventricular tachycardia).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}